In EOAD, the presence of pathogenic variants in the APP gene can trigger an excessive production of Aβ protein, and variants in PSEN1 and PSEN2 may precipitate a reduction in γ-cleavage, fostering the production of longer and more toxic forms of Aβ, contributing to the onset of AD. This evidence concerns the gene PSEN1 and Alzheimer disease.